Kyverna Therapeutics Shares Are Trading Lower. The Company Earlier Released a Presentation on KYV-101, Its CD19 CAR T-cell Candidate
Kyverna Therapeutics Shares Are Trading Lower. The Company Earlier Released a Presentation on KYV-101, Its CD19 CAR T-cell Candidate
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.